Immunisation coverage annual report, 2011

Authors

  • Brynley P Hull National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Westmead, New South Wales
  • Aditi Dey National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Westmead, New South Wales
  • Rob I Menzies National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Westmead, New South Wales
  • Julia M Brotherton Victorian Cytology Service Registries: (National HPV Vaccination Program Register and Victorian Cervical Cytology Registry)
  • Peter B McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Westmead, New South Wales

DOI:

https://doi.org/10.33321/cdi.2013.37.48

Keywords:

immunisation coverage, immunisation delay, small area coverage reporting, uman papilloma virus vaccine

Abstract

This, the 5th annual immunisation coverage report, documents trends during 2011 for a range of standard measures derived from Australian Childhood Immunisation Register data, and National Human Papillomavirus (HPV) Vaccination Program Register data. The proportion of children ‘fully vaccinated’ at 12, 24 and 60 months of age was 91.4%, 92.2% and 89.5% respectively. Although pneumococcal vaccine had similar coverage at 12 months to other vaccines, coverage was lower for rotavirus at 12 months (83.8%) and varicella at 24 months (83.9%). By late 2011, the percentage of children who received the 1st dose of diphtheria-tetanus-pertussis vaccine dose at less than 8 weeks of age was greater than 50% in 3 jurisdictions, the Australian Capital Territory, Victoria, and Queensland and at 70% for New South Wales and Tasmania. Although coverage at 12 months of age was lower among Indigenous children than non-Indigenous children in all jurisdictions, the extent of the difference varied. Overall, coverage at 24 months of age exceeded that at 12 months of age nationally. At 60 months of age, there was a marked variation between individual jurisdictions, ranging from coverage 8% lower in Indigenous children in South Australia to 6% higher in the Northern Territory. As previously documented, vaccines recommended for Indigenous children only (hepatitis A and pneumococcal polysaccharide vaccine) had suboptimal coverage at 60% and 68%, respectively. On-time receipt (before 49 months of age) of vaccines by Indigenous children at the 60-month milestone age improved between 2010 (18%) and 2011 (19%) but the disparity in on-time vaccination between Indigenous and non-Indigenous children increased at all 3 age milestones. The percentage of vaccine objectors in 2011 (1.7%) increased from 2007 when it was 1.1%. Coverage data for the 3rd dose of HPV from the national HPV register in the school catch up program was 71% but was substantially lower for the catch-up program for women outside school (39%–67%), although this was an improvement from 2010. Commun Dis Intell 2013;37(4):E291–E312.

Downloads

Download data is not yet available.

References

Hull B, Deeks S, Menzies R, McIntyre P. Immunisation coverage annual report, 2007. Commun Dis Intell 2009;33(2):170–187.

Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2008. Commun Dis Intell 2010;34(3):241–258.

Hull B, Dey A, Mahajan D, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2009. Commun Dis Intell 2011;35(2):132–148.

Hull B, Lawrence G, MacIntyre CR, et al. Immunisation coverage: Australia 2001. Canberra: Commonwealth Department of Health and Ageing; 2002.

Hull BP, McIntyre PB, Heath TC, Sayer GP. Measuring immunisation coverage in Australia. A review of the Australian Childhood Immunisation Register. Aust Fam Physician 1999;28(1):55–60.

Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Aust N Z J Public Health 2003;27(5):533–538.

Hull BP, McIntyre PB. Immunisation coverage reporting through the Australian Childhood Immunisation Register – an evaluation of the third-dose assumption. Aust N Z J Public Health 2000;24(1):17–21.

Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Estimating immunisation coverage: is the ‘third dose assumption’ still valid? Commun Dis Intell 2003;27(3):357–361.

Hull BP, McIntyre PB. Timeliness of childhood immunisation in Australia. Vaccine 2006;24(20):4403–4408.

Hull BP, McIntyre PB. What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? Commun Dis Intell 2004;28(2):238–243.

Hull BP, McIntyre PB, Couzos S. Evaluation of immunisation coverage for Aboriginal and Torres Strait Islander children using the Australian Childhood Immunisation Register. Aust N Z J Public Health 2004;28(1):47–52.

Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Is low immunisation coverage in inner urban areas of Australia due to low uptake or poor notification? Aust Fam Physician 2003;32(12):1041–1043.

Hull BP, McIntyre PB, Sayer GP. Factors associated with low uptake of measles and pertussis vaccines—an ecologic study based on the Australian Childhood Immunisation Register. Aust N Z J Public Health 2001;25(5):405–410.

Hull BP, Deeks S, Menzies R, McIntyre PB. What do we know about 7vPCV coverage in Aboriginal and Torres Strait islander children? A 2007 update. Commun Dis Intell 2008;32(2):257–260.

Lawrence GL, MacIntyre CR, Hull BP, McIntyre PB. Effectiveness of the linkage of child care and maternity payments to childhood immunisation. Vaccine 2004;22(17–18):2345–2350.

Lawrence GL, Hull BP, MacIntyre CR, McIntyre PB. Reasons for incomplete immunisation among Australian children. A national survey of parents. Aust Fam Physician 2004;33(7):568–571.

Australian Government Department of Human Services Medicare Australia. General Practice Immunisation Incentives (GPII) Scheme. 2007. Available from: http://www.medicare.gov.au/provider/incentives/gpii/index.jsp#N100D3

National Health and Medical Research Council. The Australian Immunisation Handbook. 10th edn. Australian Government Department of Health and Ageing: Canberra; 2013. Available from: http://www1.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home

O’Brien ED, Sam GA, Mead C. Methodology for measuring Australia’s childhood immunisation coverage. Commun Dis Intell 1998;22(3):36–37.

Department of Health and Aged Care. Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA). Occasional Papers, New Series No. 14. Canberra: Department of Health and Aged Care; 2001.

Rank C, Menzies RI. How reliable are Australian Childhood Immunisation Register coverage estimates for indigenous children? An assessment of data quality and coverage. Commun Dis Intell 2007;31(3):283–287.

Australian Bureau of Statistics. Australian Standard Geographical Classification (ASGC), 2001. Cat. no. 1216.0. Canberra: ABS; 2001.

MapInfo. MapInfo version 10.0 [computer program]. 7th edn. New York: MapInfo Corporation; 2009.

Australian Bureau of Statistics. Statistical Subdivision from Postal Area 2006 Concordance. Canberra: ABS; 2007. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/39433889d406eeb9ca2570610019e9a5/5942283858e38743ca25730c00009f2e!OpenDocument

Gertig DM, Brotherton JM, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011;8(2):171–178.

Department of Health. Immunise Australia. Human Papillomavirus. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv

Australian Institute of Health and Welfare. 2009 Adult Vaccination Survey – Summary results. Cat. No. PHE 135. Canberra. 2011.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011;301(Suppl):S25–S29.

Dey A, Wang H, Menzies R, Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust 2012;197(8):453–457.

Brisson M, Edmunds W, Gay N, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000;125(3):651–669.

Menzies R, Turnour C, Chiu C, McIntrye P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell 2008;32 Suppl:S2–S67.

Plotkin S, Orenstein WA, Offit PA. Vaccines 5th Edn. Elsevier; 2008.

Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19–35 months—United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58(33):921–926.

Health Protection Agency. NHS Immunisation Statistics, England 2008–09 Report. The Health and Social Care Information Centre, 2009.

National Health Performance Authority. Healthy Communities: Immunisation rates for children in 2011–12, 2013.

Ward KF, Menzies RI, Quinn HE, Campbell-Lloyd S. School-based vaccination in NSW. N S W Public Health Bull 2010;21(9–10):237–242.

Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011;35(2):197–201.

Brotherton JM, Mullins RM. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Cancer Epidemiol 2012;36(3):298–302.

Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012;206(11):1645–1651.

Ali H, Donovan B, Ward H, Read TR, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data BMJ 2013;346:F2032 [Erratum in BMJ 2013;346:F2942.]

Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377(9783):2085–2092.

Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Health Survey, 2004–05. Cat. No. 4715.0. Canberra. 2006.

Department of Health. Immunise Australia Program. Available from: http://www1.health.gov.au/internet/immunise/publishing.nsf/Content/home

Downloads

Published

01/12/13

How to Cite

Hull, Brynley P, Aditi Dey, Rob I Menzies, Julia M Brotherton, and Peter B McIntyre. 2013. “Immunisation Coverage Annual Report, 2011”. Communicable Diseases Intelligence 37 (December):291-312. https://doi.org/10.33321/cdi.2013.37.48.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>